Characterization of t(11;19)(q23;p13.3) by fluorescence in situ hybridization analysis in a pediatric patient with therapy-related acute myelogenous leukemia.

Cheng L, Ramesh KH, Radel E, Ratech H, Wei D, Cannizzaro LA

Open source

DOI
10.1016/s0165-4608(01)00429-0
Published
2001 Aug
Container
Cancer genetics and cytogenetics
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s0165-4608-01-00429-0,
  title = {Characterization of t(11;19)(q23;p13.3) by fluorescence in situ hybridization analysis in a pediatric patient with therapy-related acute myelogenous leukemia.},
  author = {Cheng L and Ramesh KH and Radel E and Ratech H and Wei D and Cannizzaro LA},
  year = {2001},
  journal = {Cancer genetics and cytogenetics},
  doi = {10.1016/s0165-4608(01)00429-0},
  url = {https://doi.org/10.1016/s0165-4608(01)00429-0}
}

RIS

TY  - JOUR
TI  - Characterization of t(11;19)(q23;p13.3) by fluorescence in situ hybridization analysis in a pediatric patient with therapy-related acute myelogenous leukemia.
AU  - Cheng L
AU  - Ramesh KH
AU  - Radel E
AU  - Ratech H
AU  - Wei D
AU  - Cannizzaro LA
PY  - 2001
JO  - Cancer genetics and cytogenetics
DO  - 10.1016/s0165-4608(01)00429-0
UR  - https://doi.org/10.1016/s0165-4608(01)00429-0
ER  - 

APA

L, C., KH, R., E, R., H, R., D, W., & LA, C. (2001). Characterization of t(11;19)(q23;p13.3) by fluorescence in situ hybridization analysis in a pediatric patient with therapy-related acute myelogenous leukemia.. Cancer genetics and cytogenetics. https://doi.org/10.1016/s0165-4608(01)00429-0

Source records